Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

• Status: Not yet recruiting
• Trial end date: 2024-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective interventional study examining the effect of ketorolac at doses of 15mg versus 30 mg for duration of analgesia in emergency department patients with suspected renal colic.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hackensack Meridian Health
• Treatments: Ketorolac

Criteria

Inclusion Criteria:

Patients will be included if they present to the Emergency Department with (all of the following):

• Adult emergency department patients < 65 years old

• Complaint of flank pain

• Pain score of 4 or greater on the 0-10 NRS

• Determination of treatment with IV ketorolac

Exclusion Criteria:

Patients will be excluded if any of the following apply:

• Allergy to ketorolac

• Pregnant patients

• Previously received analgesic medications within 4 hours prior to administration of ketorolac in our ED

• Known or stated history of renal insufficiency (eGFR < 50 ml/min/1.73 m2)

• Body weight < 50 kg

• Age greater than 65 years